Doctor Jawad Haider Butt
Rigshospitalet - Copenhagen University Hospital, Copenhagen (Denmark)
Anthropometric measures and long-term mortality in heart failure with reduced ejection: debunking the obesity paradox
Event: ESC Congress 2024
Topic: Epidemiology, Prognosis, Outcome
Session: From obesity to prediction of outcomes in acute heart failure
Effects of dapagliflozin in heart failure according to duration of type 2 diabetes: a patient-level meta-analysis of DAPA-HF and DELIVER
Event: ESC Congress 2024
Topic: Pharmacotherapy
Session: Drug therapy for heart failure: what is new?
New york heart association functional class does not modify the effect of an implantable cardioverter-defibrillator in nonischemic heart failure with reduced ejection fraction: a DANISH substudy
Event: Heart Failure 2024
Topic: Implantable Cardioverter-Defibrillator (ICD)
Session: Arrhythmias in heart failure
Effects of dapagliflozin in heart failure with preserved ejection fraction and chronic obstructive pulmonary disease: an analysis of the DELIVER trial
Event: ESC Congress 2023
Topic: Treatment
Session: State-of-the art treatment of HFmrEF and HFpEF in 2023
Dapagliflozin and PAD in HF
Event: Heart Failure 2023
Topic: Clinical
Session: Late breaking clinical trials
Kidney outcomes in heart failure trials: does endpoint definition matter?
Event: Heart Failure 2023
Topic: Treatment
Session: Chronic heart failure - treatment 5
Efficacy and safety of sacubitril/valsartan according to frailty in heart failure with preserved ejection fraction: a post hoc analysis of the PARAGON-HF trial
Event: ESC Congress 2022
Topic: Comorbidities
Session: How to treat HFpEF in 2022 and beyond
Efficacy and safety of dapagliflozin according to frailty in heart failure with reduced ejection fraction: a post hoc analysis of the DAPA-HF trial
Event: Heart Failure 2022
Topic: Pharmacotherapy
Session: Young Investigator Award: clinical research
Long-term thromboembolic risk in patients with postoperative atrial fibrillation after left-sided heart valve surgery
Event: ESC Congress 2019
Topic: Epidemiology, Prognosis, Outcome
Session: Atrial fibrillation and oral anticoagulation 6
Comparative safety and effectiveness of vitamin K antagonist and direct oral anticoagulants in patients with atrial fibrillation undergoing transcatheter aortic valve implantation
Event: ESC Congress 2019
Topic: Pharmacotherapy
Session: Transcatheter aortic interventions
